#1 Clinical Trials Search in Europe

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

  • Study of Pembrolizumab with Hyaluronidase for Patients with Relapsed or Refractory Hodgkin Lymphoma or Primary Mediastinal Large B-cell Lymphoma

    Not recruiting

    2 1 1
    Investigated drugs:
    Germany Poland Spain

  • Title: Comparing Brentuximab Vedotin plus ESHAP versus ESHAP alone in treating patients with relapsed or refractory classical Hodgkin’s Lymphoma

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Austria Croatia Greece Spain

  • Study on the Safety and Effects of AZD7789 for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Denmark France Italy Spain

  • Study of Brentuximab Vedotin, Doxorubicin Hydrochloride, and Dacarbazine for Patients with Untreated Classical Hodgkin Lymphoma

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Czechia Italy Poland Spain

  • Study of Pembrolizumab with Chemotherapy for Children and Young Adults with Classical Hodgkin Lymphoma Not Responding Well to Initial Treatment

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Czechia France Germany Greece Italy The Netherlands +2

  • Study Comparing Pembrolizumab and Brentuximab Vedotin for Patients with Relapsed or Refractory Hodgkin Lymphoma

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Czechia France Germany Italy Poland Sweden

  • Study of Tislelizumab, Gemcitabine, and Cisplatin for Patients with Relapsed or Refractory Hodgkin Lymphoma in Metabolic Complete Remission

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Denmark The Netherlands

  • Study Comparing MK-4280A (Favezelimab and Pembrolizumab) with Chemotherapy for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Belgium Czechia France Germany Poland Spain +1

  • Study of Relatlimab and Nivolumab for Children and Young Adults with Recurrent or Refractory Hodgkin and Non-Hodgkin Lymphoma

    Not recruiting

    1 1 1 1
    Investigated drugs:
    France Italy The Netherlands Spain

  • Study of Pembrolizumab and Chemotherapy for Patients with Newly Diagnosed Classical Hodgkin Lymphoma

    Not recruiting

    2 1 1 1
    Investigated drugs:
    France Italy Poland Spain